Literature DB >> 11722651

Suppressive effect of locally produced interleukin-10 on respiratory syncytial virus infection.

Y Ruan1, Y Okamoto, Z Matsuzaki, S Endo, T Matsuoka, T Kohno, H Chazono, I Eiko, K Tsubota, I Saito.   

Abstract

Interleukin (IL)-10 is known to be a multifunctional cytokine. This study was designed to evaluate the role of IL-10 during respiratory syncytial virus (RSV) infection using a C57BL/6 transgenic (TG) mouse model in which the expression of murine IL-10 cDNA was regulated by a human salivary amylase promoter (IL-10 TG mice). These mice expressed a large amount of IL-10 in the nasal mucosa and in salivary glands. Viral replication in the respiratory tract after intranasal infection with RSV was suppressed significantly in IL-10 TG mice compared to non-transgenic controls. This suppression was IL-10 specific, because it was prevented by treating mice with neutralizing anti-IL-10 antibodies. We also found that IL-10-stimulated T cells displayed cytotoxic activity against infected murine nasal epithelial cells. Previous data indicated that IL-10 induces Fas ligand (L) expression on mouse T cells. Taken together, these data suggest that Fas/Fas L mediated cytotoxicity is involved in the suppression of RSV replication observed in IL-10 TG mice after intranasal infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11722651      PMCID: PMC1783310          DOI: 10.1046/j.1365-2567.2001.01318.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  29 in total

1.  Endogenous IL-6 and IL-10 contribute to the differentiation of CD40-activated human B lymphocytes.

Authors:  N Burdin; C Van Kooten; L Galibert; J S Abrams; J Wijdenes; J Banchereau; F Rousset
Journal:  J Immunol       Date:  1995-03-15       Impact factor: 5.422

2.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

3.  Induction of intercellular adhesion molecule-1 in human nasal epithelial cells during respiratory syncytial virus infection.

Authors:  Z Matsuzaki; Y Okamoto; N Sarashina; E Ito; K Togawa; I Saito
Journal:  Immunology       Date:  1996-08       Impact factor: 7.397

4.  Fas ligand-mediated exocrinopathy resembling Sjögren's syndrome in mice transgenic for IL-10.

Authors:  I Saito; K Haruta; M Shimuta; H Inoue; H Sakurai; K Yamada; N Ishimaru; H Higashiyama; T Sumida; H Ishida; T Suda; T Noda; Y Hayashi; K Tsubota
Journal:  J Immunol       Date:  1999-03-01       Impact factor: 5.422

5.  Proinflammatory effects of IL-10 during human endotoxemia.

Authors:  F N Lauw; D Pajkrt; C E Hack; M Kurimoto; S J van Deventer; T van der Poll
Journal:  J Immunol       Date:  2000-09-01       Impact factor: 5.422

Review 6.  Models of T cell anergy: is there a common molecular mechanism?

Authors:  R H Schwartz
Journal:  J Exp Med       Date:  1996-07-01       Impact factor: 14.307

7.  Respiratory syncytial virus. I. Concentration and purification of the infectious virus.

Authors:  O Ueba
Journal:  Acta Med Okayama       Date:  1978-08       Impact factor: 0.892

8.  Systemic administration of cellular IL-10 induces an effective, specific, and long-lived immune response against established tumors in mice.

Authors:  R M Berman; T Suzuki; H Tahara; P D Robbins; S K Narula; M T Lotze
Journal:  J Immunol       Date:  1996-07-01       Impact factor: 5.422

9.  Parenteral administration of live respiratory syncytial virus vaccine: results of a field trial.

Authors:  R B Belshe; L P Van Voris; M A Mufson
Journal:  J Infect Dis       Date:  1982-03       Impact factor: 5.226

10.  Culture of human nasal epithelial cells on collagen matrix supports. A comparison of bioelectric properties of normal and cystic fibrosis epithelia.

Authors:  J R Yankaskas; C U Cotton; M R Knowles; J T Gatzy; R C Boucher
Journal:  Am Rev Respir Dis       Date:  1985-12
View more
  7 in total

1.  Differential immune responses and pulmonary pathophysiology are induced by two different strains of respiratory syncytial virus.

Authors:  Nicholas W Lukacs; Martin L Moore; Brian D Rudd; Aaron A Berlin; Robert D Collins; Sandra J Olson; Samuel B Ho; R Stokes Peebles
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

Review 2.  Understanding the mechanisms of viral induced asthma: new therapeutic directions.

Authors:  Nicole G Hansbro; Jay C Horvat; Peter A Wark; Philip M Hansbro
Journal:  Pharmacol Ther       Date:  2008-01-29       Impact factor: 12.310

Review 3.  Respiratory syncytial virus--a comprehensive review.

Authors:  Andrea T Borchers; Christopher Chang; M Eric Gershwin; Laurel J Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2013-12       Impact factor: 8.667

4.  Increased pathogenesis and inflammation of airways from respiratory syncytial virus infection in T cell deficient nude mice.

Authors:  Juan Zhou; Xi-Qiang Yang; Zhou Fu; Xiao-Dong Zhao; Li-Ping Jiang; Li-Jia Wang; Yu-Xia Cui
Journal:  Med Microbiol Immunol       Date:  2007-12-05       Impact factor: 3.402

5.  Local interleukin-10 production during respiratory syncytial virus bronchiolitis is associated with post-bronchiolitis wheeze.

Authors:  Annemieke Schuurhof; Riny Janssen; Hanneke de Groot; Hennie M Hodemaekers; Arja de Klerk; Jan Ll Kimpen; Louis Bont
Journal:  Respir Res       Date:  2011-09-12

6.  An immunocompromised BALB/c mouse model for respiratory syncytial virus infection.

Authors:  Xiaoyuan Kong; Gary R Hellermann; Geoff Patton; Mukesh Kumar; Aruna Behera; Timothy S Randall; Jian Zhang; Richard F Lockey; Shyam S Mohapatra
Journal:  Virol J       Date:  2005-02-08       Impact factor: 4.099

7.  Altered regulatory cytokine profiles in cases of pediatric respiratory syncytial virus infection.

Authors:  Ruyan Fan; Bo Wen; Wenpei Liu; Jian Zhang; Chan Liu; Chuping Fan; Xiaowang Qu
Journal:  Cytokine       Date:  2018-01-08       Impact factor: 3.861

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.